Kriska BioTech ApS: Financial statements 2025
CVR: 37591971
Source: annual report 2025, Danish Business Authority
01/10/2024 – 30/09/2025
Kriska BioTech ApS (CVR 37591971) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -25,405 and a net result of DKK -49,612 compared with DKK -44,384 the year before. Equity in the 2025 report amounted to DKK -425,023.
- Gross Profit
- DKK -25,405
- Profit/Loss
- DKK -49,612
- Equity
- DKK -425,023
- Total Assets
- DKK 137,449
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -25 t. | -50 t. | -425 t. | 0 |
| 2024 | - | -13 t. | -44 t. | -375 t. | - |
| 2023 | - | -26 t. | -61 t. | -331 t. | - |
| 2022 | - | -88 t. | -120 t. | -270 t. | - |
| 2021 | - | 39 t. | 128 | -149 t. | 1 |
Official annual report
How creditworthy is Kriska BioTech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Kriska BioTech ApS has published its annual report for 2024. Gross profit came to DKK -13,410, and the net result was DKK -44,384.
About Kriska BioTech ApS
Kriska BioTech ApS is a Danish company of the type Anpartsselskab based in Gedsted, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans Karsten Kristoffersen. The company is owned by Hans Karsten Holding ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK -25,405 and a net result of DKK -49,612 compared with DKK -44,384 the year before. Equity in the 2025 report amounted to DKK -425,023.